Adoptive Cell Therapy Market, Global Outlook and Forecast 2022-2028

April 2022 | 62 pages | ID: AE51DF1B0934EN
Market Monitor Global

Abstracts

Adoptive cell therapy, also known as cellular immunotherapy, is a form of treatment that uses the cells of our immune system to eliminate cancer.

This report contains market size and forecasts of Adoptive Cell Therapy in Global, including the following market information:

Global Adoptive Cell Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Adoptive Cell Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

CAR-T Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Adoptive Cell Therapy include Novartis, Juno, Kite, Adaptimmune, Fibrocell, Lineage Cell Therapeutics, BioTime, Vericel Corporation and Regeneus, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Adoptive Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Adoptive Cell Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Adoptive Cell Therapy Market Segment Percentages, by Type, 2021 (%)

• CAR-T
• TCR-T
• NK
• TIL

Global Adoptive Cell Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Adoptive Cell Therapy Market Segment Percentages, by Application, 2021 (%)

• Lymphoma
• Leukemia

Global Adoptive Cell Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Adoptive Cell Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Adoptive Cell Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Adoptive Cell Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Juno
• Kite
• Adaptimmune
• Fibrocell
• Lineage Cell Therapeutics
• BioTime
• Vericel Corporation
• Regeneus
• Anhui Anke Biotechnology
• Cellectis
• NantKwest
• SorrentoTherapeutics
• Bellicum

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Adoptive Cell Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Adoptive Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ADOPTIVE CELL THERAPY OVERALL MARKET SIZE

2.1 Global Adoptive Cell Therapy Market Size: 2021 VS 2028
2.2 Global Adoptive Cell Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Adoptive Cell Therapy Players in Global Market
3.2 Top Global Adoptive Cell Therapy Companies Ranked by Revenue
3.3 Global Adoptive Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Adoptive Cell Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Adoptive Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Adoptive Cell Therapy Players in Global Market
  3.6.1 List of Global Tier 1 Adoptive Cell Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Adoptive Cell Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Adoptive Cell Therapy Market Size Markets, 2021 & 2028
  4.1.2 CAR-T
  4.1.3 TCR-T
  4.1.4 NK
  4.1.5 TIL
4.2 By Type - Global Adoptive Cell Therapy Revenue & Forecasts
  4.2.1 By Type - Global Adoptive Cell Therapy Revenue, 2017-2022
  4.2.2 By Type - Global Adoptive Cell Therapy Revenue, 2023-2028
  4.2.3 By Type - Global Adoptive Cell Therapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Adoptive Cell Therapy Market Size, 2021 & 2028
  5.1.2 Lymphoma
  5.1.3 Leukemia
5.2 By Application - Global Adoptive Cell Therapy Revenue & Forecasts
  5.2.1 By Application - Global Adoptive Cell Therapy Revenue, 2017-2022
  5.2.2 By Application - Global Adoptive Cell Therapy Revenue, 2023-2028
  5.2.3 By Application - Global Adoptive Cell Therapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Adoptive Cell Therapy Market Size, 2021 & 2028
6.2 By Region - Global Adoptive Cell Therapy Revenue & Forecasts
  6.2.1 By Region - Global Adoptive Cell Therapy Revenue, 2017-2022
  6.2.2 By Region - Global Adoptive Cell Therapy Revenue, 2023-2028
  6.2.3 By Region - Global Adoptive Cell Therapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Adoptive Cell Therapy Revenue, 2017-2028
  6.3.2 US Adoptive Cell Therapy Market Size, 2017-2028
  6.3.3 Canada Adoptive Cell Therapy Market Size, 2017-2028
  6.3.4 Mexico Adoptive Cell Therapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Adoptive Cell Therapy Revenue, 2017-2028
  6.4.2 Germany Adoptive Cell Therapy Market Size, 2017-2028
  6.4.3 France Adoptive Cell Therapy Market Size, 2017-2028
  6.4.4 U.K. Adoptive Cell Therapy Market Size, 2017-2028
  6.4.5 Italy Adoptive Cell Therapy Market Size, 2017-2028
  6.4.6 Russia Adoptive Cell Therapy Market Size, 2017-2028
  6.4.7 Nordic Countries Adoptive Cell Therapy Market Size, 2017-2028
  6.4.8 Benelux Adoptive Cell Therapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Adoptive Cell Therapy Revenue, 2017-2028
  6.5.2 China Adoptive Cell Therapy Market Size, 2017-2028
  6.5.3 Japan Adoptive Cell Therapy Market Size, 2017-2028
  6.5.4 South Korea Adoptive Cell Therapy Market Size, 2017-2028
  6.5.5 Southeast Asia Adoptive Cell Therapy Market Size, 2017-2028
  6.5.6 India Adoptive Cell Therapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Adoptive Cell Therapy Revenue, 2017-2028
  6.6.2 Brazil Adoptive Cell Therapy Market Size, 2017-2028
  6.6.3 Argentina Adoptive Cell Therapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Adoptive Cell Therapy Revenue, 2017-2028
  6.7.2 Turkey Adoptive Cell Therapy Market Size, 2017-2028
  6.7.3 Israel Adoptive Cell Therapy Market Size, 2017-2028
  6.7.4 Saudi Arabia Adoptive Cell Therapy Market Size, 2017-2028
  6.7.5 UAE Adoptive Cell Therapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novartis
  7.1.1 Novartis Corporate Summary
  7.1.2 Novartis Business Overview
  7.1.3 Novartis Adoptive Cell Therapy Major Product Offerings
  7.1.4 Novartis Adoptive Cell Therapy Revenue in Global Market (2017-2022)
  7.1.5 Novartis Key News
7.2 Juno
  7.2.1 Juno Corporate Summary
  7.2.2 Juno Business Overview
  7.2.3 Juno Adoptive Cell Therapy Major Product Offerings
  7.2.4 Juno Adoptive Cell Therapy Revenue in Global Market (2017-2022)
  7.2.5 Juno Key News
7.3 Kite
  7.3.1 Kite Corporate Summary
  7.3.2 Kite Business Overview
  7.3.3 Kite Adoptive Cell Therapy Major Product Offerings
  7.3.4 Kite Adoptive Cell Therapy Revenue in Global Market (2017-2022)
  7.3.5 Kite Key News
7.4 Adaptimmune
  7.4.1 Adaptimmune Corporate Summary
  7.4.2 Adaptimmune Business Overview
  7.4.3 Adaptimmune Adoptive Cell Therapy Major Product Offerings
  7.4.4 Adaptimmune Adoptive Cell Therapy Revenue in Global Market (2017-2022)
  7.4.5 Adaptimmune Key News
7.5 Fibrocell
  7.5.1 Fibrocell Corporate Summary
  7.5.2 Fibrocell Business Overview
  7.5.3 Fibrocell Adoptive Cell Therapy Major Product Offerings
  7.5.4 Fibrocell Adoptive Cell Therapy Revenue in Global Market (2017-2022)
  7.5.5 Fibrocell Key News
7.6 Lineage Cell Therapeutics
  7.6.1 Lineage Cell Therapeutics Corporate Summary
  7.6.2 Lineage Cell Therapeutics Business Overview
  7.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Major Product Offerings
  7.6.4 Lineage Cell Therapeutics Adoptive Cell Therapy Revenue in Global Market (2017-2022)
  7.6.5 Lineage Cell Therapeutics Key News
7.7 BioTime
  7.7.1 BioTime Corporate Summary
  7.7.2 BioTime Business Overview
  7.7.3 BioTime Adoptive Cell Therapy Major Product Offerings
  7.7.4 BioTime Adoptive Cell Therapy Revenue in Global Market (2017-2022)
  7.7.5 BioTime Key News
7.8 Vericel Corporation
  7.8.1 Vericel Corporation Corporate Summary
  7.8.2 Vericel Corporation Business Overview
  7.8.3 Vericel Corporation Adoptive Cell Therapy Major Product Offerings
  7.8.4 Vericel Corporation Adoptive Cell Therapy Revenue in Global Market (2017-2022)
  7.8.5 Vericel Corporation Key News
7.9 Regeneus
  7.9.1 Regeneus Corporate Summary
  7.9.2 Regeneus Business Overview
  7.9.3 Regeneus Adoptive Cell Therapy Major Product Offerings
  7.9.4 Regeneus Adoptive Cell Therapy Revenue in Global Market (2017-2022)
  7.9.5 Regeneus Key News
7.10 Anhui Anke Biotechnology
  7.10.1 Anhui Anke Biotechnology Corporate Summary
  7.10.2 Anhui Anke Biotechnology Business Overview
  7.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Major Product Offerings
  7.10.4 Anhui Anke Biotechnology Adoptive Cell Therapy Revenue in Global Market (2017-2022)
  7.10.5 Anhui Anke Biotechnology Key News
7.11 Cellectis
  7.11.1 Cellectis Corporate Summary
  7.11.2 Cellectis Business Overview
  7.11.3 Cellectis Adoptive Cell Therapy Major Product Offerings
  7.11.4 Cellectis Adoptive Cell Therapy Revenue in Global Market (2017-2022)
  7.11.5 Cellectis Key News
7.12 NantKwest
  7.12.1 NantKwest Corporate Summary
  7.12.2 NantKwest Business Overview
  7.12.3 NantKwest Adoptive Cell Therapy Major Product Offerings
  7.12.4 NantKwest Adoptive Cell Therapy Revenue in Global Market (2017-2022)
  7.12.5 NantKwest Key News
7.13 SorrentoTherapeutics
  7.13.1 SorrentoTherapeutics Corporate Summary
  7.13.2 SorrentoTherapeutics Business Overview
  7.13.3 SorrentoTherapeutics Adoptive Cell Therapy Major Product Offerings
  7.13.4 SorrentoTherapeutics Adoptive Cell Therapy Revenue in Global Market (2017-2022)
  7.13.5 SorrentoTherapeutics Key News
7.14 Bellicum
  7.14.1 Bellicum Corporate Summary
  7.14.2 Bellicum Business Overview
  7.14.3 Bellicum Adoptive Cell Therapy Major Product Offerings
  7.14.4 Bellicum Adoptive Cell Therapy Revenue in Global Market (2017-2022)
  7.14.5 Bellicum Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Adoptive Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Adoptive Cell Therapy Market Drivers in Global Market
Table 3. Adoptive Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Adoptive Cell Therapy in Global Market
Table 5. Top Adoptive Cell Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Adoptive Cell Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Adoptive Cell Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Adoptive Cell Therapy Product Type
Table 9. List of Global Tier 1 Adoptive Cell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Adoptive Cell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Adoptive Cell Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Adoptive Cell Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Adoptive Cell Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Adoptive Cell Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Adoptive Cell Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Adoptive Cell Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Adoptive Cell Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Adoptive Cell Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Adoptive Cell Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Adoptive Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Adoptive Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Adoptive Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Adoptive Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Adoptive Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Novartis Corporate Summary
Table 31. Novartis Adoptive Cell Therapy Product Offerings
Table 32. Novartis Adoptive Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Juno Corporate Summary
Table 34. Juno Adoptive Cell Therapy Product Offerings
Table 35. Juno Adoptive Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Kite Corporate Summary
Table 37. Kite Adoptive Cell Therapy Product Offerings
Table 38. Kite Adoptive Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Adaptimmune Corporate Summary
Table 40. Adaptimmune Adoptive Cell Therapy Product Offerings
Table 41. Adaptimmune Adoptive Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Fibrocell Corporate Summary
Table 43. Fibrocell Adoptive Cell Therapy Product Offerings
Table 44. Fibrocell Adoptive Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 45. Lineage Cell Therapeutics Corporate Summary
Table 46. Lineage Cell Therapeutics Adoptive Cell Therapy Product Offerings
Table 47. Lineage Cell Therapeutics Adoptive Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 48. BioTime Corporate Summary
Table 49. BioTime Adoptive Cell Therapy Product Offerings
Table 50. BioTime Adoptive Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 51. Vericel Corporation Corporate Summary
Table 52. Vericel Corporation Adoptive Cell Therapy Product Offerings
Table 53. Vericel Corporation Adoptive Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 54. Regeneus Corporate Summary
Table 55. Regeneus Adoptive Cell Therapy Product Offerings
Table 56. Regeneus Adoptive Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 57. Anhui Anke Biotechnology Corporate Summary
Table 58. Anhui Anke Biotechnology Adoptive Cell Therapy Product Offerings
Table 59. Anhui Anke Biotechnology Adoptive Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 60. Cellectis Corporate Summary
Table 61. Cellectis Adoptive Cell Therapy Product Offerings
Table 62. Cellectis Adoptive Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 63. NantKwest Corporate Summary
Table 64. NantKwest Adoptive Cell Therapy Product Offerings
Table 65. NantKwest Adoptive Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 66. SorrentoTherapeutics Corporate Summary
Table 67. SorrentoTherapeutics Adoptive Cell Therapy Product Offerings
Table 68. SorrentoTherapeutics Adoptive Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 69. Bellicum Corporate Summary
Table 70. Bellicum Adoptive Cell Therapy Product Offerings
Table 71. Bellicum Adoptive Cell Therapy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Adoptive Cell Therapy Segment by Type in 2021
Figure 2. Adoptive Cell Therapy Segment by Application in 2021
Figure 3. Global Adoptive Cell Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Adoptive Cell Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Adoptive Cell Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Adoptive Cell Therapy Revenue in 2021
Figure 8. By Type - Global Adoptive Cell Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Adoptive Cell Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Adoptive Cell Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Adoptive Cell Therapy Revenue Market Share, 2017-2028
Figure 12. US Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Adoptive Cell Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Adoptive Cell Therapy Revenue Market Share, 2017-2028
Figure 24. China Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Adoptive Cell Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Adoptive Cell Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Adoptive Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis Adoptive Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Juno Adoptive Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Kite Adoptive Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Adaptimmune Adoptive Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Fibrocell Adoptive Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Lineage Cell Therapeutics Adoptive Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. BioTime Adoptive Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Vericel Corporation Adoptive Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Regeneus Adoptive Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Anhui Anke Biotechnology Adoptive Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Cellectis Adoptive Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. NantKwest Adoptive Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. SorrentoTherapeutics Adoptive Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Bellicum Adoptive Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)